UnitedHealth Group Incorporated $UNH Stock Holdings Raised by Robeco Institutional Asset Management B.V.

Key Points

• Robeco Institutional Asset Management increased its UnitedHealth position by 30% in the third quarter, adding 224,397 shares to hold 973,563 shares valued at approximately $357.4 million. Institutional investors collectively own 87.86% of UNH.
• UnitedHealth exceeded quarterly expectations with adjusted EPS of $4.69 versus the $4.14 consensus and revenue of $112.7 billion, while maintaining 2026 EPS guidance near $20.50. Analysts hold a consensus “Moderate Buy” rating with an average price target of $463.57.
• Despite renewed optimism around margin recovery, Optum growth and AI efficiencies, risks include medical-cost inflation, regulatory pressure, Medicare Advantage enrollment changes and valuation concerns. CEO Patrick Conway also sold 1,169 shares, reducing his direct stake by 7.09%.

Robeco Institutional Asset Management B.V. lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 30.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 973,563 shares of the healthcare conglomerate's stock after acquiring an additional 224,397 shares during the period. Robeco Institutional Asset Management B.V. owned approximately 0.11% of UnitedHealth Group worth $357,376,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. Corient Private Wealth LP purchased a new stake in UnitedHealth Group during the 2nd quarter valued at $245,516,000. Legal & General Group Plc purchased a new position in shares of UnitedHealth Group in the second quarter worth $2,444,928,000. Jupiter Topco LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at $2,019,844,000. BlackRock Inc. boosted its position in shares of UnitedHealth Group by 4.6% during the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock valued at $31,946,594,000 after buying an additional 3,395,530 shares during the last quarter. Finally, Canada Pension Plan Investment Board bought a new stake in UnitedHealth Group in the 2nd quarter worth about $971,757,000. 87.86% of the stock is owned by institutional investors.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: A Seeking Alpha analyst initiated coverage with a Strong Buy rating and a $533 price target, citing margin recovery, improved Optum Health contracts and AI-related efficiencies as potential drivers of double-digit EPS growth through 2028. The analyst also viewed UNH’s valuation as discounted relative to the healthcare sector. UnitedHealth: Optum's Recovery Supports My Strong Buy Rating
• Positive Sentiment: UnitedHealth was selected as a CNBC “Final Trades” stock after its better-than-expected quarterly results, adding to favorable short-term investor sentiment. Twilio, Transocean and a Health Care Stock on CNBC's Final Trades
• Positive Sentiment: Analysts and investors are reassessing UNH after the earnings beat and raised outlook, while commentary suggests the stock’s recent momentum reflects renewed confidence in medical-cost trends and operational execution. UnitedHealth Group Has The Market Asking A Bigger Question
• Neutral Sentiment: UnitedHealth’s results have renewed interest in healthcare ETFs with UNH exposure, although diversification may reduce the impact of company-specific gains and limit direct upside. Healthcare ETFs to Buy as UnitedHealth Beats on Q3 Earnings
• Negative Sentiment: A competing analyst downgraded UNH from Strong Buy to Buy, arguing that the shares may already reflect much of the recovery at roughly 20 times forward earnings. Valuation, medical-cost pressure and execution risks remain concerns. UnitedHealth: My Thesis Has Played Out, I Wouldn't Chase Here
• Negative Sentiment: Reports of rising healthcare costs, reduced services and higher prescription-drug prices for older Americans could increase political scrutiny and pressure insurers’ affordability and retention metrics. Older Americans Brace for Higher Healthcare Costs Ahead of Midterms
• Negative Sentiment: Declining individual-market enrollment and reports that millions of seniors may lose Medicare Advantage plans highlight regulatory, membership and pricing risks for the broader insurance industry, including UNH. 3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the company's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.19% of the stock is owned by company insiders.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $419.70 on Wednesday. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $376.72 billion, a PE ratio of 23.97, a price-to-earnings-growth ratio of 1.47 and a beta of 0.60. The firm's 50 day moving average price is $387.40 and its 200-day moving average price is $387.49. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company had revenue of $112.70 billion during the quarter, compared to analyst estimates of $111.31 billion. During the same period in the previous year, the business posted $2.59 earnings per share. The firm's quarterly revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 20.64 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were given a dividend of $2.32 per share. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.2%. UnitedHealth Group's payout ratio is presently 53.00%.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Zacks Research cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 14th. JPMorgan Chase & Co. lifted their price target on shares of UnitedHealth Group from $516.00 to $524.00 and gave the stock an "overweight" rating in a research note on Friday, October 16th. Bank of America reissued a "buy" rating and set a $450.00 price objective on shares of UnitedHealth Group in a report on Monday, July 20th. Mizuho increased their price objective on shares of UnitedHealth Group from $470.00 to $493.00 and gave the company an "outperform" rating in a research report on Monday, July 20th. Finally, BMO Capital Markets set a $512.00 target price on shares of UnitedHealth Group in a report on Tuesday, July 21st. Twenty research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $463.57.

About UnitedHealth Group

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.